Enhancing Clinical Trial Diversity: Strategies for Inclusive Patient Engagement
Join the live webinar for an insightful session focused on improving diversity in clinical trials through practical strategies for engaging underrepresented populations.
Date: December 11, 2024
Time: 12:00 – 1:00 PM ET
The speakers will explore real-world examples and discuss cultural nuances that can impact patient participation and understanding. Through role-playing scenarios and expert insights, attendees will gain practical tips for addressing language barriers and enhancing cultural competency in clinical research. This session is essential for professionals committed to inclusive trial practices that ensure equitable access to clinical innovations.
Upon completion of this continuing education program, participants should be able to:
- Develop cultural competency by recognizing how different cultural practices influence participation and patient engagement.
- Navigate potential conflicts between cultural healing practices and modern medicine in clinical trials and learn strategies to address these conflicts with sensitivity and respect.
- Acquire practical strategies for conducting informed consent discussions and working with non-English-speaking patients in clinical trials.
Speakers:
Otis Johnson, PHD, MPA
Principal Consultant
Trial Equity
Dr. Otis Johnson is a distinguished figure in clinical research and a passionate health equity advocate. His career began with a transformative 13-year tenure in scientific and operational roles at Merck. He later enhanced clinical development strategies at Syneos Health and ICON and led the growth of Clario’s Trial Oversight analytics business into a major success. Dr. Johnson is recognized as a PharmaVoice 100 most inspiring industry leader and has received numerous awards for his work in diversity, equity, and inclusion, including the 2024 Healthcare Businesswomen’s Association’s (HBA) Honorable Mentor Award. Currently, he is the Co-founder of Trial Equity, aiming to improve patient representation in clinical trials to ensure that medicines are safe and effective for all people. In his last role, he was Chief Diversity, Inclusion & Sustainability Officer at Clario.
Linda Acholonu, MBA
Project Director
Fortrea
Linda Acholonu is an accomplished expert in Clinical Drug Development, bringing over 20 years of diverse experience in the biotechnology and pharmaceuticals industry. As a Project Director at Fortrea, she oversees the management of Phase I-IV clinical trials, focusing primarily on oncology. Linda has a proven track record of successfully navigating the complexities of clinical research, ensuring compliance with regulatory standards, and fostering collaboration among cross-functional teams. Her strategic insights and dedication have contributed significantly to advancing clinical research and bringing innovative therapies to improve patients’ quality of life. Through her work, Linda aims to enhance treatment options and strives to make a meaningful impact on patient outcomes and the overall healthcare landscape.
Approved for 1.0 ACRP Contact Hours